What the name refers to
A compounded or investigational topical use of dutasteride without broadly standardised authorised formulations.
Evidence and regulatory context
The broad ingredient name is not enough to determine approval. Regulatory status belongs to the exact finished product, formulation, intended use and jurisdiction.
Reading product records
Route, vehicle and concentration can materially change a topical product. A page about an approved oral or ophthalmic medicine does not automatically validate a compounded hair formulation or an unapproved research product using the same active ingredient.
Primary research links
Use current regulator and study records rather than treating a catalogue description as medical evidence.